Moreover, AAT inhibits the metalloproteinase domain 17 [43] and the type II transmembrane serine protease [39], two host proteases facilitating SARS-CoV-2 viral entry, replication and the pathogenesis of viral infections. The gene discussed is SERPINA1; the disease is viral infectious disease.